201 related articles for article (PubMed ID: 33289788)
41. Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis.
Liu R; Zheng S; Peng S; Yu Y; Fang J; Tan S; Yao F; Guo Z; Shao Y
Biomed Res Int; 2020; 2020():2159704. PubMed ID: 33145343
[TBL] [Abstract][Full Text] [Related]
42. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.
Wang L; Liu Y; Lyu C; Buchner A; Pohla H
Biomed Res Int; 2021; 2021():8851035. PubMed ID: 33614788
[TBL] [Abstract][Full Text] [Related]
44. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
[TBL] [Abstract][Full Text] [Related]
45. The Prognostic Value of Small Noncoding microRNA-21 Expression in the Survival of Cancer Patients: A Meta-Analysis.
Binabaj MM; Bahrami A; Khazaei M; Avan A; Ferns GA; Soleimanpour S; Ryzhikov M; Hassanian SM
Crit Rev Eukaryot Gene Expr; 2020; 30(3):207-221. PubMed ID: 32749107
[TBL] [Abstract][Full Text] [Related]
46. Effect of miR-196a inhibition on esophageal cancer growth in vitro.
Bai M; Dong Y; Zhou C; Sun X; Ma J; Han S
Anticancer Drugs; 2020 Feb; 31(2):169-176. PubMed ID: 31743132
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of the MicroRNA-29 family in multiple human cancers: A meta-analysis and systematic review.
Qi Y; Huang Y; Pang L; Gu W; Wang N; Hu J; Cui X; Zhang J; Zhao J; Liu C; Zhang W; Zou H; Li F
Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):441-454. PubMed ID: 28063172
[TBL] [Abstract][Full Text] [Related]
48. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.
Kong X; Du Y; Wang G; Gao J; Gong Y; Li L; Zhang Z; Zhu J; Jing Q; Qin Y; Li Z
Dig Dis Sci; 2011 Feb; 56(2):602-9. PubMed ID: 20614181
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of microRNAs in gastric cancer: a meta-analysis.
Zhang Y; Guan DH; Bi RX; Xie J; Yang CH; Jiang YH
Oncotarget; 2017 Aug; 8(33):55489-55510. PubMed ID: 28903436
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920
[TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
52. Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma.
Sang C; Chao C; Wang M; Zhang Y; Luo G; Zhang X
Aging (Albany NY); 2020 May; 12(10):9807-9824. PubMed ID: 32412911
[TBL] [Abstract][Full Text] [Related]
53. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of microRNA-9 in cancers: a systematic review and meta-analysis.
Sun H; Shao Y; Huang J; Sun S; Liu Y; Zhou P; Yang H
Oncotarget; 2016 Oct; 7(41):67020-67032. PubMed ID: 27563807
[TBL] [Abstract][Full Text] [Related]
55. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers.
Pan B; He B; Xu X; Liu X; Xu T; Xu M; Chen X; Zeng K; Lin K; Hu X; Sun L; Pan Y; Sun H; Wang S
Cancer Manag Res; 2019; 11():5437-5457. PubMed ID: 31354351
[No Abstract] [Full Text] [Related]
58. Prognostic Value of MicroRNA-497 in Various Cancers: A Systematic Review and Meta-Analysis.
Liu Z; Wu S; Wang L; Kang S; Zhao B; He F; Liu X; Zeng Y; Liu J
Dis Markers; 2019; 2019():2491291. PubMed ID: 31191744
[TBL] [Abstract][Full Text] [Related]
59. LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p.
Zhong F; Zhang W; Cao Y; Wen Q; Cao Y; Lou B; Li J; Shi W; Liu Y; Luo R; Chen C
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1190-1199. PubMed ID: 30383193
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
